Psilera Closes $8.8M Series Seed Extension Funding Round

Deal Summary

Psilera, a Tampa‑based biopharmaceutical company, announced the closing of an $8.8 million Series Seed extension round. The round was oversubscribed and led by a syndicate of institutional and strategic investors, providing capital to advance its neuroplastogen pipeline.